Bausch Health Companies Inc. Common Stock (NY:BHC)

5.890 +0.090 (+1.55%)

Official Closing Price Updated: 7:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bausch Health Companies Inc. Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

BAUSCH HEALTH COMPANIES INC. (NYSE: BHC) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bausch Health Companies Inc.

July 28, 2023

From Bernstein Liebhard LLP

Via GlobeNewswire

Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Bausch Health Companies Inc. (BHC)

July 27, 2023

From Robbins LLP

Via Business Wire

BHC EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Encourages Bausch Health Companies Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BHC

July 27, 2023

From The Rosen Law Firm, P.A.

Via Business Wire

Ortho Dermatologics Announces 2023 Aspire Higher Scholarship Recipients

July 27, 2023

Via ACCESSWIRE

Salix Announces 2023 Gastrointestinal Health Scholars Program Winners

July 11, 2023

Via ACCESSWIRE

Why Shares of Bausch Health Jumped on Friday ↗

July 07, 2023

Global investment powerhouse KKR will be providing the healthcare company with increased liquidity.

Via The Motley Fool

Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 17, 2023

Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived...

Via Benzinga

Bausch Health to Announce Second-Quarter 2023 Results on Aug. 3

July 13, 2023

Via ACCESSWIRE

Breather For Carl Icahn: Revised Loan Agreements and Recovery Strategy Post Short-Seller Attack ↗

July 10, 2023

Activist investor Carl Icahn has been struggling to recover after a short-seller attack led to a 40% drop in his investment company's shares, Icahn Enterprises L.P. (NASDAQ: IEP), alarming major banks...

Via Benzinga

Salix to Present Data from XIFAXAN(R) (Rifaximin) Clinical Research at EASL's International Liver Congress(TM) 2023

June 19, 2023

Via ACCESSWIRE

Why Bausch Health Companies Stock Is Tanking Today ↗

June 06, 2023

The never-ending saga over generic Xifaxan is weighing on the drugmaker's stock today.

Via The Motley Fool

OraPharma to Participate in the First-Ever Research and Technology Pavilion Sponsored by Pacific Dental Services(R) at the American Dental Hygienists' Association (ADHA(R)) Annual Conference

July 07, 2023

Via ACCESSWIRE

Bausch Health Enters Into $600 Million Financing Facility With KKR

July 07, 2023

Via ACCESSWIRE

Bausch + Lomb Poised To Boost Presence In Growing Market With Potential $1.75B Drug Acquisition Deal From Novartis ↗

June 30, 2023

Bausch + Lomb Corporation (NYSE: BLCO) has agreed to acquire 'front of eye' ophthalmology assets for $1.75 billion in upfront cash, plus additional milestone payments from Novartis AG (NYSE:

Via Benzinga

Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R)

June 30, 2023

Via ACCESSWIRE

Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2023 ↗

June 16, 2023

Via Benzinga

Why Shares of Bausch Health Soared Wednesday ↗

May 17, 2023

The company won a big patent fight with a generic-drug maker.

Via The Motley Fool

Bausch Health Announces 2023 Annual Meeting of Shareholder Results

May 17, 2023

Via ACCESSWIRE

Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

June 06, 2023

Gainers Recruiter.com Group, Inc. (NASDAQ: RCRT) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement for planned purchase of fintech assets of GoLogiq.

Via Benzinga

Coinbase, Blue Bird, Tingo Group And Other Big Stocks Moving Lower On Tuesday ↗

June 06, 2023

U.S. stocks traded mixed, with the Nasdaq Composite rising around 0.2% on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Salix Pharmaceuticals to Deliver Podium Presentation at Digestive Disease Week(R) 2023

May 08, 2023

Via ACCESSWIRE

Why Bausch Health Stock Is Tumbling Today ↗

May 04, 2023

Bausch Health Companies Inc (NYSE: BHC) reported Q1 FY23 revenues of $1.94 billion, up 1% Y/Y, up 4% organic basis, missing the consensus

Via Benzinga

Recap: Bausch Health Companies Q1 Earnings ↗

May 04, 2023

Via Benzinga

Bausch Health Responds to Norwich's ANDA Tentative Approval and Lawsuit Against United States Food and Drug Administration

June 06, 2023

Via ACCESSWIRE

Zoetis Declares New Dividend, Hinting At Undervaluation

May 18, 2023

Zoetis shareholders woke up to news of JAB's acquisition of Pumpkin, a per insurance platform where Zoetis owns a minority stake. 2023 outlooks suggest a rally

Via MarketBeat

Bausch Health Options Traders: Stock Will Remain Below This Level Through July Expiration ↗

May 18, 2023

Bausch Health Companies Inc. (NYSE: BHC) shares rose sharply on Wednesday.

Via Benzinga

New Clinical Study Suggests the Use of OraPharma’s ARESTIN(R) (minocycline HCl) Microspheres, 1mg May Decrease Certain Pathogens in Adults with Periodontitis

May 18, 2023

Via ACCESSWIRE

U.S. District Court Upholds Final Judgment for XIFAXAN(R) 550 mg That Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029

May 17, 2023

Via ACCESSWIRE

Bausch Health Observes Mental Health Awareness Month

May 10, 2023

Via ACCESSWIRE

Why Synaptics Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

May 04, 2023

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 89.3% to $7.44.

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.